CYTOKINETICS INC(CYTK)内部人交易:高管与董事近期交易
过去 18 个月,共有 15 位内部人为 CYTOKINETICS INC(CYTK)报告了 275 笔 Form 4 交易(最近一笔 2026-11-18)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-18 | Blum Robert I | President & CEO | 买入 | 7,500 | $79,500 |
| 2026-11-18 | Malik Fady Ibraham | EVP Research & Development | 买入 | 3,500 | $27,300 |
| 2026-11-18 | Hessekiel Jeffrey | Chief Legal & Admin Officer | 卖出 | 15,106 | $794,878 |
| 2026-11-18 | Blum Robert I | President & CEO | 卖出 | 5,077 | $270,198 |
| 2026-11-18 | Malik Fady Ibraham | EVP Research & Development | 卖出 | 3,300 | $170,709 |
| 2026-11-18 | Blum Robert I | President & CEO | 卖出 | 2,223 | $120,220 |
| 2026-11-18 | Malik Fady Ibraham | EVP Research & Development | 卖出 | 200 | $10,518 |
| 2026-11-18 | Blum Robert I | President & CEO | 卖出 | 200 | $11,042 |
| 2026-11-12 | PARSHALL B LYNNE | 董事 | 卖出 | 2,445 | $132,446 |
| 2026-11-12 | PARSHALL B LYNNE | 董事 | 卖出 | 2,555 | $141,189 |
| 2026-11-03 | Malik Fady Ibraham | EVP Research & Development | 买入 | 3,500 | $27,300 |
| 2026-11-03 | Malik Fady Ibraham | EVP Research & Development | 卖出 | 3,500 | $220,255 |
| 2026-11-02 | Blum Robert I | President & CEO | 买入 | 7,500 | $79,500 |
| 2026-11-02 | Blum Robert I | President & CEO | 卖出 | 7,500 | $471,075 |
| 2026-10-20 | HENDERSON JOHN T | 董事 | 买入 | 352 | $22,500 |
| 2026-10-20 | WIERENGA WENDELL | 董事 | 买入 | 97 | $6,200 |
| 2026-10-20 | Wysenski Nancy | 董事 | 买入 | 97 | $6,200 |
| 2026-10-20 | Kaye Edward M. MD | 董事 | 买入 | 195 | $12,464 |
| 2026-10-20 | Malik Fady Ibraham | EVP Research & Development | 买入 | 3,500 | $27,300 |
| 2026-10-20 | Daly James M | 董事 | 买入 | 195 | $12,464 |
| 2026-10-20 | Harrington Robert Arthur | 董事 | 买入 | 195 | $12,464 |
| 2026-10-20 | Malik Fady Ibraham | EVP Research & Development | 卖出 | 3,500 | $224,035 |
| 2026-10-13 | Blum Robert I | President & CEO | 买入 | 7,500 | $79,500 |
| 2026-10-13 | Blum Robert I | President & CEO | 卖出 | 7,500 | $471,600 |
| 2026-10-06 | Malik Fady Ibraham | EVP Research & Development | 买入 | 3,500 | $27,300 |
来源:SEC Form 4 申报文件 · 截至 2026-11-18